It's All About Access

Today’s guest blog comes from Steven Stapleton, Senior Director of Strategy Operations and Customer Interaction at Lilly.

It's a fact: Many Americans worry about money. But when someone is diagnosed with a life-changing condition such as diabetes or osteoporosis, the focus should be on how to get healthier, not how he or she will pay for medicine. That's the reality for many people and that’s why I'm passionate about Lilly TruAssist programs. At Lilly, it’s part of my job to make sure that we meet the medical needs of people in the communities where we live and work. Programs like Lilly TruAssist help people in the United States who face financial hardships gain access to the treatments they need.

I’m particularly proud to say that Lilly’s patient assistance programs have helped over a million people and provided those patients over $2 billion in medication in the last five years. It's encouraging to see how these programs make a difference for people every day. But don't take my word for it. See for yourself how these programs helped just a few TruAssist participants live longer, healthier lives:

I truly believe that our responsibility to people doesn’t stop when our medicines leave the production line. It includes working across sectors to provide access to our medicines to those who need them. When we do this, we're also delivering on our promise to make life better for people around the world.

 

Did you notice a new name at the top of this post? LillyPad is proud to partner with a variety of guest bloggers from around the world, and we're committed to hosting a range of viewpoints on our site. However, please note that the views contained in this post belong to its author and are not necessarily endorsed by Lilly.